Goldman Sachs Upgrades Qiagen NV (QGEN) to Neutral
Tweet
Share
E-mailGet Alerts QGEN Hot Sheet
Price: $42.95 --0%
Rating Summary:
14 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Rating Summary:
14 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Join SI Premium – FREE
Goldman Sachs upgraded Qiagen NV (NASDAQ: QGEN) from Sell to Neutral with a price target of $17.00 (from $15.00).
The firm cited: 1) we now view FY2012 guidance and Street estimates as reasonable, (2) believe HPV headwinds are better understood, and (3) now incorporate an M&A ranking in our price target methodology as we expect M&A premiums in Diagnostics to persist.
For an analyst ratings summary and ratings history on Qiagen NV click here. For more ratings news on Qiagen NV click here.
Shares of Qiagen NV closed at $16.70 yesterday.
The firm cited: 1) we now view FY2012 guidance and Street estimates as reasonable, (2) believe HPV headwinds are better understood, and (3) now incorporate an M&A ranking in our price target methodology as we expect M&A premiums in Diagnostics to persist.
For an analyst ratings summary and ratings history on Qiagen NV click here. For more ratings news on Qiagen NV click here.
Shares of Qiagen NV closed at $16.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Citi Upgrades Zhejiang Dahua Technology (002236:CH) to Neutral
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
